Showing results (271-280 of 371) with videos related to

Sort By:
Pageof 38
Lancet (London, England)|August 11, 1990
Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumoursD Grandér, K Oberg, M L Lundqvist, et al.
World Journal of Surgery|October 19, 2000
Method for dissection of mesenteric metastases in mid-gut carcinoid tumorsU Ohrvall, B Eriksson, C Juhlin, et al.
World Journal of Surgery|September 1, 1996
Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type IB Skogseid, K Oberg, B Eriksson, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 27, 2005
Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomographyH Orlefors, A Sundin, L Lu, et al.
Acta Endocrinologica|February 1, 1990
A polyclonal antiserum against chromogranin A and B--a new sensitive marker for neuroendocrine tumoursB Eriksson, H Arnberg, K Oberg, et al.
The British Journal of Radiology|May 1, 1989
Relative proton density and relaxation times in liver metastases during interferon treatmentT Andersson, A Ericsson, B Eriksson, et al.
Acta Endocrinologica|March 1, 1989
A new pituitary protein 7B2 is increased in patients with high alpha- or beta-hCGU Leonhardt, B Eriksson, K Oberg, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
Chromogranins--new sensitive markers for neuroendocrine tumorsB Eriksson, H Arnberg, K Oberg, et al.
Italian Journal of Gastroenterology and Hepatology|December 22, 1999
Positron emission tomography in neuroendocrine tumoursB Eriksson, H Orlefors, A Sundin, et al.
European Journal of Immunology|November 9, 2000
The basic helix-loop-helix transcription factor E2-2 is involved in T lymphocyte developmentI Bergqvist, M Eriksson, J Saarikettu, et al.
Pageof 38